Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease.

Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease. Int Angiol. 2014 Jun; 33(3):236-42.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.